Efficacy and Safety Study of SUNPG1622

NCT02980705 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

180

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated-Sponsor's decision

Conditions

Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis

Interventions

DRUG: SUNPG1622 I dose
DRUG: Placebo dose

Sponsor

Sun Pharmaceutical Industries Limited